cas 287729-03-7|| where to buy tert-butyl allyl(1,3-dioxoisoindolin-2-yl)carbamate

Название продукции:tert-butyl allyl(1,3-dioxoisoindolin-2-yl)carbamate

IUPAC Name:N-(1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl)-N-(prop-2-en-1-yl)(tert-butoxy)formamide

Упаковочная единица	Доступно для заказа	Цена ($)
CM263007-100mg	in stock	Ǻş
CM263007-250mg	in stock	ƻƻǠ
CM263007-1g	in stock	ŭşȋ
CM263007-5g	in stock	şşş

Только для использования в НИОКР..

Форма запроса

Химическое название

Номер CAS

Количество*

Необходимые спецификации*
(% пробы, категория материала и т.д.)

Контактное лицо*

Электронная почта*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 287729-03-7 regularly via the above email.

Дополнительные примечания

Verification code*

refresh

: Номер CAS:287729-03-7; Молекулярная формула:C16H18N2O4; Точка плавления:-; Smiles-код:O=C(OC(C)(C)C)N(CC=C)N(C(C1=C2C=CC=C1)=O)C2=O; Плотность:

: Номер в каталоге:CM263007; Молекулярная масса:302.33; Точка кипения:; Номер Mdl:; Хранение:

: Wee1 inhibitors; Wee1 protein is the most well-known Wee protein, and Wee1 protein kinases are members of the serine/threonine family and are highly conserved in evolution and are abundantly present in many eukaryotes and are very active in the S and G2 phases of the cell cycle. Wee1 protein kinase is a key regulatory center in DNA replication, chromosomal concentration, and histone transcription. These biological behavioral abnormalities can lead to genomic instability and cause malignant tumors, but inhibition or down-regulation of Wee1 protein kinase expression in malignant tumors can trigger mitotic catastrophe and apoptosis leads to tumor cell death. It has now been found that the expression of Wee1 is up-regulated in many cancers, and it has been clinically found that treatment with an inhibitor of Wee1 can effectively improve the occurrence and development of cancer. At present, many companies have deployed this target, and some have progressed to the clinical stage. Some Wee1 inhibitors under development include Adavosertib(ADZ1775), Azenosertib, ZNL-06-096, Debio-0123 and SGR-3515.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.